Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$21.21 USD
+0.26 (1.24%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $21.21 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth C Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Amphastar Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Generic Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AMPH 21.21 +0.26(1.24%)
Will AMPH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMPH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMPH
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
Bausch Health (BHC) Lags Q2 Earnings Estimates
AMPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Amphastar (AMPH) a New Buy Stock
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
Here's Why Amphastar (AMPH) is Poised for a Turnaround After Losing 13.1% in 4 Weeks
Other News for AMPH
Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More
Amphastar Pharmaceuticals Inc (AMPH) Announces Second Quarter 2025 Earnings Release and ...
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August ...
Amphenol (AMPH) Anticipates Strong Q3 Revenue Growth Amid Electronics Boom | AMPH Stock News
Amphastar sees Q3 adjusted EPS 77c-79c, consensus 69c